Company
Montis Biosciences
Dual-mechanism Antibodies to Harness C1q’s Central Role in Neuroinflammatory Diseases
Also known as Montis Biosciences BV
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Leuven, Belgium
- Legal name
- Montis Biosciences BV
Claim, correct or request removal
Record updated 28 September 2026
About
Montis Biosciences is a biotechnology company developing next-generation therapeutics that harness the dual biology of complement C1q by simultaneously targeting the complement and myeloid axes, two fundamental drivers of autoimmune and neurodegenerative diseases.
Loading relationship preview